NCT07260318

Brief Summary

The goal of this study is to investigate the acute effects of cricket fast bowling on the bone turnover and signaling markers in healthy young males. The main question aims to answer: • Does a single bout acute fast bowling change serum C-terminal telopeptide of type I collagen (CTX-I) and other bone turnover and signaling markers levels? Participants complete both the bowling and control trials, with a minimum washout period of one week between trials. During each trial, blood samples are collected at three time points: pre-, immediately post, and 2-hour post bowling/rest.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2023

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

2.9 years

First QC Date

November 14, 2025

Last Update Submit

November 20, 2025

Conditions

Keywords

CricketFast bowlingBone turnoverStress injuries

Outcome Measures

Primary Outcomes (1)

  • Serum C-terminal telopeptide of type I collagen (CTX-I) concentration

    Serum CTX-I concentration is measured using electrochemiluminescence immunoassay (ECLIA) and reported in nanograms per milliliter (ng/mL).

    Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.

Secondary Outcomes (7)

  • Serum N-terminal propeptide of type I collagen (PINP) concentration

    Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.

  • Serum parathyroid hormone (PTH) concentration

    Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.

  • Serum sclerostin concentration

    Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.

  • Serum dickkopf Wnt signaling pathway inhibitor 1 (DKK1) concentration

    Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.

  • Serum osteoprotegerin (OPG) concentration

    Blood samples are collected at baseline, immediately after the bowling or the corresponding rest period, and 2 hours after the second blood sample collection.

  • +2 more secondary outcomes

Study Arms (2)

Arm Bowling + Control

EXPERIMENTAL

Participants first perform the bowling trial, followed by the control trial, with a minimum interval of one week between the two trials.

Behavioral: Exercise

Arm Control + Bowling

EXPERIMENTAL

Participants first perform the control trial, followed by the bowling trial, with a minimum interval of one week between the two trials.

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

During the bowling trial, participants perform 8 sets of 6 deliveries (bowl at match intensity throughout), followed by 2-hour rest. Each set is interspersed by a 3-minute randomized fielding simulation. During the control trial, participants rest throughout instead of bowling.

Arm Bowling + ControlArm Control + Bowling

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male
  • Aged 18 - 30
  • Cricket fast bowlers (a ball speed of \~100kmh) playing for a university team or above, such as British Universities and Colleges Sport (BUCS) or University Centre of Cricketing Excellence (UCCE)
  • Injury free for the last 3 months

You may not qualify if:

  • Diagnosed with any disease or use of any medication that affects bone turnover
  • Fracture experienced within the previous year/season

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loughborough Univeristy

Loughborough, Leicestershire, LE11 3TU, United Kingdom

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Katherine Brooke-Wavell

    Loughborough University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 14, 2025

First Posted

December 3, 2025

Study Start

February 20, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

December 3, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations